306 related articles for article (PubMed ID: 23702908)
1. Diagnosis of diabetes remission after bariatic surgery may be jeopardized by remission criteria and previous hypoglycemic treatment.
Ramos-Levi A; Sanchez-Pernaute A; Matia P; Cabrerizo L; Barabash A; Hernandez C; Calle-Pascual A; Torres A; Rubio M
Obes Surg; 2013 Oct; 23(10):1520-6. PubMed ID: 23702908
[TBL] [Abstract][Full Text] [Related]
2. Remission of type 2 diabetes mellitus should not be the foremost goal after bariatric surgery.
Ramos-Levi AM; Sanchez-Pernaute A; Cabrerizo L; Matia P; Barabash A; Hernandez C; Calle-Pascual AL; Torres AJ; Rubio MA
Obes Surg; 2013 Dec; 23(12):2020-5. PubMed ID: 23893315
[TBL] [Abstract][Full Text] [Related]
3. Statistical models to predict type 2 diabetes remission after bariatric surgery.
Ramos-Levi AM; Matia P; Cabrerizo L; Barabash A; Sanchez-Pernaute A; Calle-Pascual AL; Torres AJ; Rubio MA
J Diabetes; 2014 Sep; 6(5):472-7. PubMed ID: 24433454
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status.
Blackstone R; Bunt JC; Cortés MC; Sugerman HJ
Surg Obes Relat Dis; 2012; 8(5):548-55. PubMed ID: 22721581
[TBL] [Abstract][Full Text] [Related]
5. Bariatric surgery versus conventional medical therapy for type 2 diabetes.
Mingrone G; Panunzi S; De Gaetano A; Guidone C; Iaconelli A; Leccesi L; Nanni G; Pomp A; Castagneto M; Ghirlanda G; Rubino F
N Engl J Med; 2012 Apr; 366(17):1577-85. PubMed ID: 22449317
[TBL] [Abstract][Full Text] [Related]
6. Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery.
Aarts EO; Janssen J; Janssen IM; Berends FJ; Telting D; de Boer H
Obes Surg; 2013 Jul; 23(7):867-73. PubMed ID: 23475775
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: impact of surgical techniques.
Robert M; Ferrand-Gaillard C; Disse E; Espalieu P; Simon C; Laville M; Gouillat C; Thivolet C
Obes Surg; 2013 Jun; 23(6):770-5. PubMed ID: 23355293
[TBL] [Abstract][Full Text] [Related]
8. "Dual-remission" after Roux-en-Y gastric bypass surgery: Glycemic variability cannot always be improved in Chinese obese patients with type 2 diabetes.
Yu H; Zhou J; Bao Y; Pin Zhang ; Lu W; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1312-1319. PubMed ID: 26823091
[TBL] [Abstract][Full Text] [Related]
9. Relationships between type 2 diabetes remission after gastric bypass and different weight loss metrics: arguments against excess weight loss in metabolic surgery.
van de Laar AW; de Brauw LM; Meesters EW
Surg Obes Relat Dis; 2016 Feb; 12(2):274-82. PubMed ID: 26476492
[TBL] [Abstract][Full Text] [Related]
10. Duration of type 2 diabetes and remission rates after bariatric surgery in Sweden 2007-2015: A registry-based cohort study.
Jans A; Näslund I; Ottosson J; Szabo E; Näslund E; Stenberg E
PLoS Med; 2019 Nov; 16(11):e1002985. PubMed ID: 31747392
[TBL] [Abstract][Full Text] [Related]
11. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m
Di J; Zhang H; Yu H; Zhang P; Wang Z; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1357-1363. PubMed ID: 27387699
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with complete and partial remission, improvement, or unchanged diabetes status of obese adults 1 year after sleeve gastrectomy.
Elgenaied I; El Ansari W; Elsherif MA; Abdulrazzaq S; Qabbani AS; Elhag W
Surg Obes Relat Dis; 2020 Oct; 16(10):1521-1530. PubMed ID: 32680788
[TBL] [Abstract][Full Text] [Related]
13. Five-Year-Results of Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass for Weight Loss and Type 2 Diabetes Mellitus.
Seki Y; Kasama K; Haruta H; Watanabe A; Yokoyama R; Porciuncula JP; Umezawa A; Kurokawa Y
Obes Surg; 2017 Mar; 27(3):795-801. PubMed ID: 27644433
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Predictive Factors of Successful Weight Loss and Glycaemic Control 1 Year After Gastric Bypass for Morbid Obesity.
Palmisano S; Silvestri M; Giuricin M; Baldini E; Albertario S; Capelli P; Marzano B; Fanti G; Zompicchiatti A; Millo P; Fabozzi M; Brachet Contul R; Ponte E; Allieta R; de Manzini N
Obes Surg; 2015 Nov; 25(11):2040-6. PubMed ID: 25845353
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Relapse of Hyperglycemia after Laparoscopic Roux-en-Y Gastric Bypass in T2DM Obese Patients: a 5-Year Follow-Up of 24 Cases.
Xiaosong W; Chongyu S; Xuqi S; Peiwu Y; Yongliang Z
Obes Surg; 2019 Apr; 29(4):1164-1168. PubMed ID: 30645722
[TBL] [Abstract][Full Text] [Related]
16. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.
Malin SK; Bena J; Abood B; Pothier CE; Bhatt DL; Nissen S; Brethauer SA; Schauer PR; Kirwan JP; Kashyap SR
Diabetes Obes Metab; 2014 Dec; 16(12):1230-8. PubMed ID: 25132119
[TBL] [Abstract][Full Text] [Related]
17. Effect of Roux-en-Y Gastric Bypass on Remission of T2D: Medium-Term Follow-up in Chinese Patients with Different BMI Obesity Class.
Zhang H; Han X; Yu H; Di J; Zhang P; Jia W
Obes Surg; 2017 Jan; 27(1):134-142. PubMed ID: 27312346
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m(2).
Yang J; Wang C; Cao G; Yang W; Yu S; Zhai H; Pan Y
BMC Surg; 2015 Jul; 15():88. PubMed ID: 26198306
[TBL] [Abstract][Full Text] [Related]
19. C-peptide levels predict type 2 diabetes remission after bariatric surgery.
Ramos-Leví AM; Matía P; Cabrerizo L; Barabash A; Torrejón MJ; Sánchez-Pernaute A; Torres AJ; Rubio MA
Nutr Hosp; 2013; 28(5):1599-603. PubMed ID: 24160222
[TBL] [Abstract][Full Text] [Related]
20. The impact of bariatric surgery on insulin-treated type 2 diabetes patients.
Lemus R; Karni D; Hong D; Gmora S; Breau R; Anvari M
Surg Endosc; 2018 Feb; 32(2):990-1001. PubMed ID: 28842774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
